Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
35.41
-0.85 (-2.34%)
At close: Nov 28, 2025, 1:00 PM EST
35.69
+0.28 (0.79%)
After-hours: Nov 28, 2025, 4:00 PM EST
Travere Therapeutics Stock Forecast
Stock Price Forecast
The 14 analysts that cover Travere Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $37.21, which forecasts a 5.08% increase in the stock price over the next year. The lowest target is $25 and the highest is $47.
Price Target: $37.21 (+5.08%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Travere Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 7 | 7 |
| Buy | 8 | 8 | 8 | 8 | 7 | 6 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 16 | 16 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +32.73% | Nov 28, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $26 → $35 | Hold | Maintains | $26 → $35 | -1.16% | Nov 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $30 → $40 | Strong Buy | Maintains | $30 → $40 | +12.96% | Oct 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +32.73% | Sep 19, 2025 |
| Stifel | Stifel | Hold Maintains $20 → $25 | Hold | Maintains | $20 → $25 | -29.40% | Sep 12, 2025 |
Financial Forecast
Revenue This Year
486.60M
from 233.18M
Increased by 108.68%
Revenue Next Year
682.38M
from 486.60M
Increased by 40.23%
EPS This Year
-0.93
from -4.08
EPS Next Year
-0.13
from -0.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 572.3M | 892.5M | ||||
| Avg | 486.6M | 682.4M | ||||
| Low | 389.2M | 459.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 145.4% | 83.4% | ||||
| Avg | 108.7% | 40.2% | ||||
| Low | 66.9% | -5.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.55 | 2.84 | ||||
| Avg | -0.93 | -0.13 | ||||
| Low | -1.51 | -7.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.